Product Information

Registration Status: Active

DBL HYOSCINE INJECTION BP 400mcg/ML is approved to be sold in Singapore with effective from 1989-12-07. It is marketed by HOSPIRA SINGAPORE PTE LTD, with the registration number of SIN03610P.

This product contains Hyoscine Hydrobromide 400mcg/ml in the form of INJECTION. It is approved for INTRAVENOUS, SUBCUTANEOUS, INTRAMUSCULAR use.

This product is manufactured by Hospira Australia Pty Ltd in GERMANY, andhameln pharmaceuticals GmbH in AUSTRALIA.

It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.

Hyoscine Hydrobromide

Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.


  1. Health Science Authority of Singapore - Reclassified POM
  2. Drugbank